Cargando…

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review

Patients with severe hemophilia A (HA) have an increased risk of spontaneous and trauma‐related bleeding because of a congenital absence of factor VIII (FVIII). Most severe HA patients use prophylactic FVIII concentrate, the effect of which can be monitored with FVIII activity level measurement. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verhagen, Marieke J. A., Valke, Lars L. F. G., Schols, Saskia E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305107/ https://www.ncbi.nlm.nih.gov/pubmed/35034413 http://dx.doi.org/10.1111/jth.15640

Ejemplares similares

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation
por: Valke, Lars L.F.G., et al.
Publicado: (2020)

Thrombin generation and implications for hemophilia therapies: A narrative review
por: Sidonio, Robert F., et al.
Publicado: (2022)

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype
por: Verhagen, Marieke J.A., et al.
Publicado: (2023)

Applicability of the Thrombin Generation Test to Evaluate the Hemostatic Status of Hemophilia A Patients in Daily Clinical Practice
por: Bernardo, Ángel, et al.
Publicado: (2022)

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations
por: Duarte, Rita Carolina Figueiredo, et al.
Publicado: (2017)

Clinical use of topical thrombin as a surgical hemostat
por: Lew, Wesley K, et al.
Publicado: (2008)

Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States
por: Sharathkumar, Anjali, et al.
Publicado: (2023)

Acquired Hemophilia A: Bleeding Pattern and Hemostatic Therapeutic Strategies
por: Marino, Renato
Publicado: (2023)

Hemostatic effect and distribution of new rhThrombin formulations in rats
por: Kochan, Jan, et al.
Publicado: (2014)

Use of a gelatin-thrombin hemostatic matrix in obstetrics and gynecological surgery
por: Mısırlıoğlu, Selim, et al.
Publicado: (2018)

Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
por: Doshi, Bhavya S., et al.
Publicado: (2012)

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy
por: Zhuang, Baoxiong, et al.
Publicado: (2015)

Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes
por: Mathews, Natalie, et al.
Publicado: (2022)

Effects of Thrombin-Based Hemostatic Agent in Total Knee Arthroplasty: Meta-Analysis
por: Park, Jung-Wee, et al.
Publicado: (2023)

Comparison of Two Gelatin and Thrombin Combination Hemostats in a Porcine Liver Abrasion Model
por: Lewis, Kevin M., et al.
Publicado: (2013)

Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL(®), in intracranial tumor resection
por: Kamamoto, Dai, et al.
Publicado: (2020)

Diagnostic Accuracy in Acute Venous Thromboembolism: Comparing D-Dimer, Thrombin Generation, Overall Hemostatic Potential, and Fibrin Monomers
por: Farm, Maria, et al.
Publicado: (2020)

Thrombin@Fe(3)O(4) nanoparticles for use as a hemostatic agent in internal bleeding
por: Shabanova, Emiliya M., et al.
Publicado: (2018)

Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
por: Négrier, Claude, et al.
Publicado: (2022)

Hemostatic agents for prehospital hemorrhage control: a narrative review
por: Peng, Henry T.
Publicado: (2020)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Postoperative Spinal Epidural Hematoma: The Danger Caused by the Misuse of Thrombin-Containing Local Hemostatics
por: Ahn, Dong Ki, et al.
Publicado: (2017)

Past, present and future of hemophilia: a narrative review
por: Franchini, Massimo, et al.
Publicado: (2012)

Predictors for hemostatic thrombin-gelatin matrix usage in spine surgery: a multicenter observational study
por: Kato, So, et al.
Publicado: (2023)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

A Narrative Review of Different Hemostatic Materials in Emergency Treatment of Trauma
por: Xiao, Xiaoxiao, et al.
Publicado: (2022)

The efficacy of a thrombin-based hemostatic agent in primary total knee arthroplasty: a meta-analysis
por: Wang, Chen, et al.
Publicado: (2014)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Gelatin-thrombin hemostatic matrix injection to salvage refractory post-renal graft biopsy bleed
por: Jain, V., et al.
Publicado: (2013)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere
por: Xuan, Fengqi, et al.
Publicado: (2017)

Limited factor VIIa surface localization requirement of the factor VIIa–induced overall thrombin generation in platelet‐rich hemophilia A plasma
por: Persson, Egon, et al.
Publicado: (2019)

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)

Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control
por: Bruckner, Brian A., et al.
Publicado: (2021)

Hemostatic Dysfunction in Dogs Naturally Infected with Angiostrongylus vasorum—A Narrative Review
por: Willesen, Jakob L., et al.
Publicado: (2022)

Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model
por: Pittman, Debra D., et al.
Publicado: (2022)

In Vitro Effects on Thrombin of Paris Saponins and In Vivo Hemostatic Activity Evaluation of Paris fargesii var. brevipetala
por: Wen, Feiyan, et al.
Publicado: (2019)

Use of thrombin generation test for monitoring hemostasis in coronary bypass surgery
por: Gruzdeva, Olga, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5q77871ptkn21jl9st634s6v28